FR2753204B1 - Procede de preparation d'adn plasmidique - Google Patents

Procede de preparation d'adn plasmidique

Info

Publication number
FR2753204B1
FR2753204B1 FR9611075A FR9611075A FR2753204B1 FR 2753204 B1 FR2753204 B1 FR 2753204B1 FR 9611075 A FR9611075 A FR 9611075A FR 9611075 A FR9611075 A FR 9611075A FR 2753204 B1 FR2753204 B1 FR 2753204B1
Authority
FR
France
Prior art keywords
preparation
plasmid dna
plasmid
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9611075A
Other languages
English (en)
Other versions
FR2753204A1 (fr
Inventor
Bruno Cavallini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Priority to FR9611075A priority Critical patent/FR2753204B1/fr
Priority to EP97940209A priority patent/EP0958358A1/fr
Priority to AU42128/97A priority patent/AU733057B2/en
Priority to CA002266123A priority patent/CA2266123A1/fr
Priority to JP51331498A priority patent/JP2001503971A/ja
Priority to PCT/FR1997/001594 priority patent/WO1998011208A1/fr
Publication of FR2753204A1 publication Critical patent/FR2753204A1/fr
Application granted granted Critical
Publication of FR2753204B1 publication Critical patent/FR2753204B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/101—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4707—Muscular dystrophy
    • C07K14/4708—Duchenne dystrophy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
FR9611075A 1996-09-11 1996-09-11 Procede de preparation d'adn plasmidique Expired - Fee Related FR2753204B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9611075A FR2753204B1 (fr) 1996-09-11 1996-09-11 Procede de preparation d'adn plasmidique
EP97940209A EP0958358A1 (fr) 1996-09-11 1997-09-10 Procede de preparation d'adn plasmidique
AU42128/97A AU733057B2 (en) 1996-09-11 1997-09-10 Method of preparing plasmid DNA
CA002266123A CA2266123A1 (fr) 1996-09-11 1997-09-10 Procede de preparation d'adn plasmidique
JP51331498A JP2001503971A (ja) 1996-09-11 1997-09-10 プラスミドｄｎａの調製法
PCT/FR1997/001594 WO1998011208A1 (fr) 1996-09-11 1997-09-10 Procede de preparation d'adn plasmidique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9611075A FR2753204B1 (fr) 1996-09-11 1996-09-11 Procede de preparation d'adn plasmidique

Publications (2)

Publication Number Publication Date
FR2753204A1 FR2753204A1 (fr) 1998-03-13
FR2753204B1 true FR2753204B1 (fr) 1998-12-04

Family

ID=9495642

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9611075A Expired - Fee Related FR2753204B1 (fr) 1996-09-11 1996-09-11 Procede de preparation d'adn plasmidique

Country Status (6)

Country Link
EP (1) EP0958358A1 (fr)
JP (1) JP2001503971A (fr)
AU (1) AU733057B2 (fr)
CA (1) CA2266123A1 (fr)
FR (1) FR2753204B1 (fr)
WO (1) WO1998011208A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7026468B2 (en) 1996-07-19 2006-04-11 Valentis, Inc. Process and equipment for plasmid purification
US7807822B2 (en) 1996-08-01 2010-10-05 Robert Bridenbaugh Methods for purifying nucleic acids
US6214586B1 (en) * 1997-12-08 2001-04-10 Genzyme Corporation Method for purifying plasmid DNA and plasmid DNA substantially free of genomic DNA
GB0127803D0 (en) * 2001-11-20 2002-01-09 Glaxo Group Ltd Processing nucleic acid
US7314746B2 (en) 2002-09-13 2008-01-01 Valentis, Inc. Apparatus and method for preparative scale purification of nucleic acids
US8501402B2 (en) 2003-03-24 2013-08-06 Boehringer Ingelheim Rcv Gmbh & Co Kg Methods and devices for producing biomolecules
EP1462519A1 (fr) 2003-03-24 2004-09-29 Boehringer Ingelheim Austria GmbH Méthodes et appareilles pour la production de molécules biologiques
WO2004094634A1 (fr) * 2003-04-22 2004-11-04 Arkray Inc. Procede d'isolation d'acide nucleique et trousse et appareil pour l'isolation d'acide nucleique
JP2007006799A (ja) * 2005-06-30 2007-01-18 Tokyo Institute Of Technology プラスミドｄｎａの精製方法及びプラスミドｄｎａ精製用キット
EP2088196A1 (fr) 2008-02-08 2009-08-12 Boehringer Ingelheim RCV GmbH & Co KG Procédés et dispositifs pour la production de biomolécules
EP2912175B1 (fr) * 2012-10-23 2018-08-22 Toolgen Incorporated Composition pour le clivage d'un adn cible comprenant un arn guide spécifique de l'adn cible et un acide nucléique codant pour la protéine cas ou la protéine cas, et leur utilisation
WO2021123402A1 (fr) 2019-12-20 2021-06-24 Engenes Biotech Gmbh Bioproduction continue par découplage de la croissance et de la production
WO2024003799A1 (fr) 2022-06-29 2024-01-04 Takeda Pharmaceutical Company Limited Procédé de production d'acides nucléiques extrachromosomiques
EP4299753A1 (fr) 2022-06-29 2024-01-03 enGenes Biotech GmbH Procédé de production d'acides nucléiques extrachromosomiques

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2598435A1 (fr) * 1986-05-06 1987-11-13 Clonatec Sa Procede et dispositif pour la detection de genomes viraux a adn et arn dans les milieux biologiques, notamment dans le serum sanguin
WO1992018514A1 (fr) * 1991-04-12 1992-10-29 Minnesota Mining And Manufacturing Company Purification d'acides nucleiques a l'aide de supports en oxyde m tallique
US5561064A (en) * 1994-02-01 1996-10-01 Vical Incorporated Production of pharmaceutical-grade plasmid DNA
AR003122A1 (es) * 1995-05-19 1998-07-08 Merck & Co Inc Un proceso para aislacion y purificacion de plasmidos en fermentadores de gran escala y el adn aislado y purificado obtenido mediante dicho proceso.

Also Published As

Publication number Publication date
EP0958358A1 (fr) 1999-11-24
CA2266123A1 (fr) 1998-03-19
AU4212897A (en) 1998-04-02
JP2001503971A (ja) 2001-03-27
AU733057B2 (en) 2001-05-03
FR2753204A1 (fr) 1998-03-13
WO1998011208A1 (fr) 1998-03-19

Similar Documents

Publication Publication Date Title
FR2777562B1 (fr) Procede de purification d'aminonitriles aliphatiques
PL331202A1 (en) Polynucleotidic vaccine composition for treating horses' diseases
MA24426A1 (fr) Procede pour la preparation de nouveaux composes
EP0554376A4 (en) Dna construct for providing rna therapy
FR2749778B1 (fr) Procede de preparation de catalyseurs d'hydrotraitement
MA23395A1 (fr) Procede de preparation de nouvelles formulations
FR2753204B1 (fr) Procede de preparation d'adn plasmidique
FR2764211B1 (fr) Procede de preparation de catalyseurs d'hydrotraitement
FR2750704B1 (fr) Procede de production d'adn therapeutique
MA24246A1 (fr) Procede de preparation de frites dorees au four ameliorees
FR2746412B1 (fr) Purification d'adn plasmidique de qualite pharmaceutique
MA24355A1 (fr) Procede de preparation de nouveaux composes
FR2687687B1 (fr) Procede pour mesurer la taille de fragments d'adn.
FR2778661B1 (fr) Procede de preparation d'aminonitrile et de diamine
MA24182A1 (fr) Procede pour la preparation de 2,4-diaminopyrimidines substituees
IL121730A0 (en) Process for the preparation of 2'-fluoro-5-methyl-beta-L-arabino-furanosyluridine
FR2744648B1 (fr) Procede de preparation d'agents tensioactifs
FR2754816B1 (fr) Procede de purification d'hydrogenochlorofluoroethanes
FR2771091B1 (fr) Procede d'hydrogenation de dinitriles
FR2760024B1 (fr) Procede de caracterisation de duplex d'acide nucleique
FR2768725B1 (fr) Procede de preparation du 2-chloroprop-1-ene
FR2733227B1 (fr) Procede pour la preparation de 1,1-difluoroethane
FR2739373B1 (fr) Procede de preparation de catalyseurs d'ammoxydation
MA24245A1 (fr) Procede pour la preparation de nouveaux composes sulfonylures
MA24464A1 (fr) Procede de preparation de composes nouveaux .

Legal Events

Date Code Title Description
ST Notification of lapse